Study might be better described as a cost description of screening

BMJ 1996; 312 doi: https://doi.org/10.1136/bmj.312.7035.909b (Published 06 April 1996) Cite this as: BMJ 1996;312:909
  1. Sarah Walters
  1. Senior lecturer in public health and epidemiology University of Birmingham, Birmingham B15 2TT

    EDITOR,—H S Cuckle and colleagues' paper on the cost effectiveness of antenatal screening for cystic fibrosis raises several important questions.1 Firstly, their choice of cost effectiveness analysis rather than cost-benefit analysis makes an implicit assumption that the goal of a screening programme is to reduce births of affected infants and thus reduce health expenditure. This can be achieved only by introducing screening into a situation where there is high uptake (that is, antenatal clinics) and maximisation of the rate of subsequent termination of affected pregnancies. This is …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription